Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2755–2765. doi: 10.1158/1055-9965.EPI-08-0388

Table 2.

ORs and 95% CIs for the association between polymorphisms in CASR and colon cancer risk

All colon cancer Proximal colon cancer Distal colon cancer
Position/ Genotype Controls
N
Cases
N
OR* 95% CI P for trend Cases
N
OR* 95%CI P for trend Cases
N
OR* 95%CI P for trend
-465T>C
(rs6678267)
CC 1270 1039 1.00 - 505 1.00 - 508 1.00 -
CT 563 485 1.07 0.93-1.24 232 1.05 0.87-1.26 242 1.10 0.91-1.32
TT 87 56 0.80 0.57-1.13 0.93 26 0.75 0.48-1.18 0.69 28 0.83 0.54-1.29 0.82
TT + CT vs. CC 1.04 0.90-1.19 1.01 0.84-1.21 1.06 0.89-1.27
IVS1+2998A>G
(rs672782)
GG 778 643 1.00 - 311 1.00 - 315 1.00 -
GA 869 713 1.01 0.87-1.17 337 0.98 0.82-1.18 360 1.05 0.88-1.26
AA 272 219 0.98 0.80-1.21 0.93 110 1.02 0.79-1.32 0.97 103 0.94 0.72-1.23 0.88
AA + GA vs. GG 1.00 0.88-1.15 0.99 0.84-1.18 1.02 0.86-1.21
IVS1+12198G>A
(rs6802749)
GG 1329 1097 1.00 - 517 1.00 - 554 1.00 -
GA 544 444 1.00 0.86-1.16 224 1.07 0.88-1.28 207 0.93 0.77-1.12
AA 62 42 0.81 0.54-1.21 0.55 20 0.83 0.49-1.38 0.91 22 0.83 0.50-1.37 0.31
AA + GA vs. GG 0.98 0.85-1.13 1.04 0.87-1.25 0.92 0.76-1.10
IVS1+25086G>A
(rs17203502)
GG 526 431 1.00 - 218 1.00 - 204 1.00 -
GA 953 780 0.98 0.84-1.15 370 0.93 0.76-1.13 388 1.03 0.84-1.26
AA 461 382 0.99 0.82-1.20 0.92 180 0.93 0.73-1.17 0.51 194 1.05 0.83-1.33 0.68
AA + GA vs. GG 0.99 0.85-1.15 0.93 0.77-1.12 1.03 0.86-1.25
IVS1-18718C>A
(rs1354162)
CC 1530 1283 1.00 - 625 1.00 - 629 1.00 -
CA 338 267 0.95 0.79-1.13 122 0.89 0.71-1.12 137 0.99 0.79-1.23
AA 29 17 0.71 0.39-1.29 0.29 8 0.67 0.31-1.48 0.18 8 0.67 0.31-1.49 0.57
AA + CA vs. CC 0.93 0.78-1.10 0.87 0.70-1.09 0.96 0.78-1.20
IVS1-4705C>T
(rs9875101)
CC 957 784 1.00 - 371 1.00 - 395 1.00 -
CT 804 663 1.00 0.87-1.15 314 1.01 0.84-1.20 332 0.99 0.83-1.18
TT 178 143 0.97 0.77-1.24 0.89 82 1.19 0.89-1.59 0.37 57 0.77 0.56-1.06 0.25
TT + CT vs. CC 1.00 0.87-1.14 1.04 0.88-1.23 0.95 0.81-1.13
IVS1-160T>C
(rs34178491)
TT 1339 1121 1.00 - 535 1.00 - 560 1.00 -
CT 515 416 0.97 0.83-1.13 206 1.01 0.83-1.22 198 0.92 0.76-1.12
CC 58 40 0.83 0.55-1.25 0.42 21 0.91 0.55-1.52 0.88 19 0.79 0.47-1.35 0.27
CC + CT vs. TT 0.96 0.82-1.11 1.00 0.83-1.20 0.91 0.76-1.10
IVS3+298A>T
rs3749204
AA 482 419 1.00 - 214 1.00 - 197 1.00 -
AT 930 765 0.97 0.82-1.14 354 0.87 0.71-1.07 393 1.06 0.87-1.31
TT 472 373 0.93 0.77-1.13 0.50 181 0.88 0.70-1.12 0.29 181 0.96 0.76-1.23 0.77
TT + AT vs. AA 0.96 0.82-1.11 0.88 0.72-1.06 1.03 0.85-1.25
IVS3+1048G>T
(rs10934578)
GG 907 731 1.00 - 344 1.00 - 365 1.00 -
GT 864 711 1.04 0.90-1.19 337 1.04 0.87-1.25 361 1.06 0.89-1.26
TT 169 152 1.13 0.89-1.44 0.33 86 1.35 1.01-1.81 0.09 62 0.93 0.67-1.27 0.98
TT + GT vs. GG 1.05 0.92-1.20 1.09 0.92-1.29 1.04 0.88-1.23
IVS3-685G>A
(rs12485716)
GG 955 799 1.00 - 411 1.00 - 372 1.00 -
AG 784 630 0.95 0.82-1.09 293 0.86 0.72-1.03 321 1.04 0.87-1.24
AA 173 148 0.98 0.77-1.25 0.61 58 0.75 0.54-1.04 0.03 85 1.20 0.90-1.61 0.27
AA + AG vs. GG 0.95 0.83-1.09 0.84 0.71-1.00 1.07 0.90-1.26
IVS4+2761C>T
(rs35387386)
CC 1823 1516 1.00 - 730 1.00 - 747 1.00 -
CT 104 64 0.73 0.53-1.00 30 0.71 0.47-1.08 34 0.78 0.52-1.16
TT 1 1 - - 0.06 1 - - - 0 - - 0.18
TT + CT vs. CC 0.73 0.53-1.00 0.73 0.48-1.10 0.77 0.52-1.14
IVS4-1185C>T
(rs35780274)
CC 628 535 1.00 - 257 1.00 - 267 1.00 -
CT 917 732 0.96 0.82-1.12 340 0.92 0.76-1.12 369 0.97 0.80-1.17
TT 365 303 1.01 0.83-1.22 0.96 161 1.10 0.87-1.40 0.57 138 0.93 0.72-1.18 0.54
TT + CT vs. CC 0.97 0.84-1.12 0.97 0.81-1.17 0.96 0.80-1.15
IVS5-90C>T
(rs4678174)
TT 840 708 1.00 - 363 1.00 - 332 1.00 -
CT 865 670 0.90 0.78-1.04 314 0.83 0.69-0.99 335 0.97 0.81-1.16
CC 239 214 1.00 0.81-1.25 0.57 90 0.83 0.62-1.09 0.05 119 1.19 0.91-1.54 0.41
CC + CT vs. TT 0.92 0.81-1.06 0.83 0.70-0.98 1.01 0.85-1.20
IVS6+16T>C
(rs2270916)
TT 1425 1202 1.00 - 593 1.00 - 584 1.00 -
CT 476 365 0.94 0.80-1.10 169 0.87 0.71-1.07 183 0.97 0.80-1.19
CC 40 28 0.85 0.52-1.39 0.32 7 0.43 0.19-0.97 0.04 20 1.27 0.73-2.19 0.82
CC + CT vs. TT 0.93 0.80-1.08 0.84 0.69-1.02 1.00 0.82-1.21
Ex7+1224G>T
A986S (rs1801725)
GG 1476 1197 1.00 - 572 1.00 - 594 1.00 -
GT 430 371 1.08 0.92-1.26 182 1.10 0.90-1.34 181 1.06 0.87-1.30
TT 33 27 1.00 0.60-1.67 0.45 14 1.08 0.58-2.04 0.37 13 0.95 0.50-1.83 0.68
TT + GT vs. GG 1.07 0.92-1.25 1.10 0.91-1.33 1.05 0.87-1.28
Ex7+1236A>G
R990G (rs1042636)
AA 1640 1347 1.00 - 646 1.00 - 670 1.00 -
GA 262 224 1.04 0.86-1.27 112 1.09 0.85-1.38 106 1.00 0.78-1.27
GG 12 7 0.72 0.28-1.84 0.88 5 1.06 0.37-3.03 0.51 2 0.41 0.09-1.86 0.65
GG + GA vs. AA 1.03 0.85-1.25 1.09 0.86-1.37 0.97 0.76-1.24
Ex7+1299G>C
E1011Q (rs1801726)
CC 1725 1425 1.00 - 684 1.00 - 707 1.00 -
CG 180 149 0.97 0.77-1.22 77 1.06 0.80-1.41 68 0.88 0.66-1.19
GG 5 4 0.74 0.19-2.84 0.71 2 0.79 0.15-4.23 0.77 2 0.72 0.14-3.86 0.38
GG + CG vs. CC 0.97 0.77-1.21 1.05 0.80-1.40 0.88 0.66-1.18
Global P 0.52 0.10 0.93
*

Adjusted for age, race, sex and study center.

Only 1 case and control with TT genotype, thus estimates are not provided.